European Consumers Use of Internet for Pharmaceutical Information

Manhattan ResearchIn today's world of fragmented media and channel mix, it is increasingly difficult to isolate the information sources used by consumers to research health information and inform healthcare decision making. This is especially the case across Europe, where consumers are accessing an expanding range of resources which vary greatly by country and by region.

Enter Cybercitizen® Health Europe, a new research study and advisory service offered by Manhattan Research. This study provides pharmaceutical and healthcare companies with key data about the evolving nature of consumer channel mix, media and technology usage, and healthcare information with the goal of helping companies understand how consumers across Europe access health information, and how they use that information to make critical healthcare decisions for themselves and their families.

In addition to defining broad online health technology trends, Cybercitizen® Health Europe will investigate topics such as Internet usage, search engine usage, local European versus global websites, product websites, health portals, health information seeking methods, email communication, patient-physician interactions, unbranded patient education, health e-commerce and more. Furthermore, the study will reveal leading health and pharma websites based on the number of visiting European consumers, while detailing consumer satisfaction with site content and features.

Webinar Presentation
A free, private webinar is offered to qualified business accounts to review additional information about Cybercitizen® Health Europe as well as charter sponsorship details. Please visit www.manhattanresearch.com/ccheu.aspx to register for the webinar or to request additional information.

The Cybercitizen® Health Europe syndicated multi-client study and advisory service will be fielded as an online panel study among 3,300 European consumers in total from the United Kingdom, Germany, Spain, Italy, France, Belgium, Sweden, the Netherlands, Poland, and Portugal. The study will explore these topics and many more:

  • Overall media consumption
  • Frequency and types of Internet access
  • Technology adoption like MP3/iPod, PDA, SMS messaging, Smartphones
  • Advanced activities online like online video, blogs, podcasting, wikis
  • Use and relative influence of physicians, nurses, pharmacists, friends and family
  • Search engine reliance and behaviour
  • Use and interest in health email newsletters, support groups, chat rooms, and disease management tools
  • Interest in Web 2.0 technologies for health and pharmaceutical information

About Manhattan Research Products and Service
In addition to Cybercitizen® Health Europe, Manhattan Research conducts five annual research studies among consumers and physicians in the United States and in Europe. These studies include Cybercitizen® Health US, Taking the Pulse® Europe, Taking the Pulse® US, ePharma Physician®, and ePharma Consumer®. Each study serves a unique purpose and focuses on specific aspects of information technology adoption. Broad consumer and physician research is complemented by targeted analysis among more than 50 consumer therapeutic segments and 25 physician specialist segments. For further information, please visit www.manhattanresearch.com

Most Popular Now

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...

AI Analysis of PET/CT Images can Predict…

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious...